RadNet Debt to Equity Ratio 2012-2026 | RDNT
Current and historical debt to equity ratio values for RadNet (RDNT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. RadNet debt/equity for the three months ending March 31, 2026 was 0.79.
| RadNet Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $2.53B | $1.35B | 1.87 |
| 2025-12-31 | $2.40B | $1.36B | 1.77 |
| 2025-09-30 | $2.35B | $1.31B | 1.79 |
| 2025-06-30 | $2.34B | $1.18B | 1.98 |
| 2025-03-31 | $2.20B | $1.14B | 1.94 |
| 2024-12-31 | $2.15B | $1.13B | 1.90 |
| 2024-09-30 | $2.16B | $1.12B | 1.93 |
| 2024-06-30 | $2.14B | $1.09B | 1.96 |
| 2024-03-31 | $1.89B | $1.08B | 1.76 |
| 2023-12-31 | $1.88B | $0.81B | 2.31 |
| 2023-09-30 | $1.89B | $0.80B | 2.38 |
| 2023-06-30 | $1.94B | $0.76B | 2.56 |
| 2023-03-31 | $1.92B | $0.49B | 3.90 |
| 2022-12-31 | $1.94B | $0.49B | 3.95 |
| 2022-09-30 | $1.79B | $0.46B | 3.90 |
| 2022-06-30 | $1.79B | $0.45B | 3.96 |
| 2022-03-31 | $1.72B | $0.42B | 4.08 |
| 2021-12-31 | $1.71B | $0.35B | 4.95 |
| 2021-09-30 | $1.70B | $0.34B | 5.02 |
| 2021-06-30 | $1.73B | $0.30B | 5.79 |
| 2021-03-31 | $1.55B | $0.28B | 5.50 |
| 2020-12-31 | $1.53B | $0.26B | 5.92 |
| 2020-09-30 | $1.47B | $0.25B | 5.98 |
| 2020-06-30 | $1.48B | $0.23B | 6.36 |
| 2020-03-31 | $1.49B | $0.21B | 7.20 |
| 2019-12-31 | $1.41B | $0.23B | 6.06 |
| 2019-09-30 | $1.40B | $0.22B | 6.52 |
| 2019-06-30 | $1.38B | $0.21B | 6.52 |
| 2019-03-31 | $1.31B | $0.21B | 6.15 |
| 2018-12-31 | $0.91B | $0.20B | 4.54 |
| 2018-09-30 | $0.79B | $0.12B | 6.51 |
| 2018-06-30 | $0.79B | $0.13B | 6.31 |
| 2018-03-31 | $0.81B | $0.12B | 6.94 |
| 2017-12-31 | $0.80B | $0.07B | 11.43 |
| 2017-09-30 | $0.77B | $0.07B | 10.47 |
| 2017-06-30 | $0.79B | $0.06B | 12.38 |
| 2017-03-31 | $0.80B | $0.05B | 15.08 |
| 2016-12-31 | $0.80B | $0.05B | 15.32 |
| 2016-09-30 | $0.80B | $0.04B | 19.91 |
| 2016-06-30 | $0.79B | $0.04B | 21.41 |
| 2016-03-31 | $0.81B | $0.04B | 21.53 |
| 2015-12-31 | $0.80B | $0.04B | 21.94 |
| 2015-09-30 | $0.78B | $0.03B | 29.71 |
| 2015-06-30 | $0.78B | $0.01B | 63.72 |
| 2015-03-31 | $0.74B | $0.01B | 112.54 |
| 2014-12-31 | $0.73B | $0.01B | 95.22 |
| 2014-09-30 | $0.75B | $0.00B | 284.91 |
| 2014-06-30 | $0.74B | $0.00B | -268.75 |
| 2014-03-31 | $0.75B | $-0.01B | -80.12 |
| 2013-12-31 | $0.72B | $0.00B | 325.96 |
| 2013-09-30 | $0.72B | $0.00B | 1974.50 |
| 2013-06-30 | $0.72B | $0.01B | 146.11 |
| 2013-03-31 | $0.73B | $0.00B | 449.52 |
| 2012-12-31 | $0.72B | $-0.01B | -107.35 |
| 2012-09-30 | $0.68B | $-0.06B | -11.55 |
| 2012-06-30 | $0.69B | $-0.07B | -10.66 |
| 2012-03-31 | $0.70B | $-0.07B | -10.14 |
| 2011-12-31 | $0.69B | $-0.07B | -9.87 |
| 2011-09-30 | $0.65B | $-0.08B | -8.51 |
| 2011-06-30 | $0.65B | $-0.08B | -8.41 |
| 2011-03-31 | $0.64B | $-0.08B | -7.80 |
| 2010-12-31 | $0.62B | $-0.08B | -7.54 |
| 2010-09-30 | $0.63B | $-0.09B | -7.14 |
| 2010-06-30 | $0.62B | $-0.09B | -6.99 |
| 2010-03-31 | $0.55B | $-0.08B | -6.93 |
| 2009-12-31 | $0.56B | $-0.08B | -7.43 |
| 2009-09-30 | $0.56B | $-0.08B | -7.07 |
| 2009-06-30 | $0.56B | $-0.08B | -7.23 |
| 2009-03-31 | $0.58B | $-0.08B | -6.84 |
| 2008-12-31 | $0.58B | $-0.08B | -7.12 |
| 2008-09-30 | $0.59B | $-0.07B | -7.97 |
| 2008-06-30 | $0.59B | $-0.08B | -7.65 |
| 2008-03-31 | $0.58B | $-0.08B | -7.34 |
| 2007-12-31 | $0.50B | $-0.07B | -7.21 |
| 2007-09-30 | $0.49B | $-0.05B | -9.03 |
| 2007-06-30 | $0.44B | $-0.05B | -8.92 |
| 2007-03-31 | $0.45B | $-0.05B | -9.02 |
| 2006-12-31 | $0.44B | $-0.05B | -9.40 |
| 2006-10-31 | $0.00B | 0.00 | |
| 2006-09-30 | $0.00B | 0.00 | |
| 2006-07-31 | $0.20B | $-0.08B | -2.70 |
| 2006-06-30 | $0.00B | 0.00 | |
| 2006-04-30 | $0.20B | $-0.07B | -2.67 |
| 2006-03-31 | $0.00B | 0.00 | |
| 2006-01-31 | $0.19B | $-0.07B | -2.67 |
| 2005-10-31 | $0.19B | $-0.07B | -2.72 |
| 2005-07-31 | $0.19B | $-0.07B | -2.74 |
| 2005-04-30 | $0.20B | $-0.07B | -2.78 |
| 2005-01-31 | $0.20B | $-0.07B | -2.80 |
| 2004-10-31 | $0.20B | $-0.07B | -2.89 |
| 2004-07-31 | $0.20B | $-0.06B | -3.24 |
| 2004-04-30 | $0.20B | $-0.06B | -3.50 |
| 2004-01-31 | $0.20B | $-0.05B | -3.64 |
| 2003-10-31 | $0.20B | $-0.05B | -3.68 |
| 2003-07-31 | $0.20B | $-0.05B | -3.76 |
| 2003-04-30 | $0.20B | $-0.05B | -3.89 |
| 2003-01-31 | $0.21B | $-0.05B | -3.92 |
| 2002-10-31 | $0.20B | $-0.05B | -3.98 |
| 2002-07-31 | $0.20B | $-0.05B | -4.11 |
| 2002-04-30 | $0.19B | $-0.04B | -4.37 |
| 2002-01-31 | $0.18B | $-0.04B | -4.14 |
| 2001-10-31 | $0.17B | $-0.05B | -3.81 |
| 2001-07-31 | $0.16B | $-0.05B | -3.10 |
| 2001-04-30 | $0.15B | $-0.06B | -2.75 |
| 2001-01-31 | $0.15B | $-0.06B | -2.53 |
| 2000-12-31 | $0.15B | $-0.06B | -2.49 |
| 2000-10-31 | $0.15B | $-0.06B | -2.49 |
| 2000-09-30 | $0.15B | $-0.06B | -2.37 |
| 2000-07-31 | $0.00B | 0.00 | |
| 2000-06-30 | $0.14B | $-0.06B | -2.20 |
| 2000-04-30 | $0.00B | 0.00 | |
| 2000-03-31 | $0.00B | 0.00 | |
| 2000-01-31 | $0.00B | 0.00 | |
| 1999-12-31 | $0.14B | $-0.06B | -2.12 |
| 1999-10-31 | $0.00B | 0.00 | |
| 1999-09-30 | $0.13B | $-0.06B | -2.07 |
| 1999-06-30 | $0.13B | $-0.06B | -2.10 |
| 1999-03-31 | $0.13B | $-0.06B | -2.19 |
| 1998-12-31 | $0.12B | $-0.06B | -2.13 |
| 1998-09-30 | $0.11B | $-0.03B | -3.67 |
| 1998-06-30 | $0.11B | $-0.03B | -3.82 |
| 1998-03-31 | $0.11B | $-0.03B | -4.06 |
| 1997-12-31 | $0.11B | $-0.03B | -4.47 |
| 1997-09-30 | $0.12B | $-0.03B | -3.81 |
| 1997-06-30 | $0.12B | $-0.03B | -4.02 |
| 1997-03-31 | $0.13B | $-0.03B | -4.15 |
| 1996-12-31 | $0.13B | $-0.03B | -5.26 |
| 1996-09-30 | $0.00B | $-0.02B | 0.00 |
| 1996-06-30 | $0.00B | $-0.02B | 0.00 |
| 1996-03-31 | $0.00B | $-0.02B | 0.00 |
| 1995-12-31 | $0.00B | $-0.02B | 0.00 |
| 1995-09-30 | $0.00B | $0.04B | 0.00 |
| 1995-06-30 | $0.00B | $0.04B | 0.00 |
| 1995-03-31 | $0.00B | $0.05B | 0.00 |
| 1994-12-31 | $0.00B | $0.05B | 0.00 |
| 1994-09-30 | $0.00B | $0.07B | 0.00 |
| 1994-06-30 | $0.00B | $0.07B | 0.00 |
| 1994-03-31 | $0.00B | $0.08B | 0.00 |
| 1993-12-31 | $0.00B | $0.08B | 0.00 |
| 1993-09-30 | $0.00B | $0.11B | 0.00 |
| 1993-06-30 | $0.00B | $0.13B | 0.00 |
| 1993-03-31 | $0.00B | $0.13B | 0.00 |
| 1992-12-31 | $0.00B | $0.10B | 0.00 |
| 1992-09-30 | $0.00B | $0.00B | 0.00 |
| 1992-06-30 | $0.00B | $0.07B | 0.00 |
| 1992-03-31 | $0.00B | $0.03B | 0.00 |
| 1991-12-31 | $0.00B | $0.01B | 0.00 |
| 1991-09-30 | $0.00B | $0.01B | 0.00 |
| 1991-06-30 | $0.00B | $0.01B | 0.00 |
| 1991-03-31 | $0.00B | $0.01B | 0.00 |
| 1990-12-31 | $0.00B | $0.00B | 0.00 |
| 1990-09-30 | $0.00B | $0.00B | 0.00 |
| 1990-03-31 | $0.00B | 0.00 | |
| 1989-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.302B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |